Cantallopez, Jovelyn R.

HRN: 18-43-36  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
CEFTAZIDIME 1GM (VIAL)
04/06/2026
04/12/2026
IV
2g
Q8
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  URTIFebrile Neutropenia    Compliance to guidelines: